Skip to main content

Table 1 Demographics and clinicopathological characteristics of lung carcinoid tumors

From: Prognostic nomogram for predicting long-term cancer-specific survival in patients with lung carcinoid tumors

  All (N = 1956)
Age at diagnosis, years
  < 60 952 (48.7%)
  ≥ 60 1004 ((51.3%)
Gender
 Female 1302 (66.6%)
 Male 654 (33.4%)
Race
 White 1745 (89.2%)
 Other 211 (10.8%)
Insurance
 Yes 1587 (81.1%)
 No 369 (18.9%)
Marital status
 Married 1140 (58.3%)
 Unmarried 816 (41.7%)
Primary site
 Main bronchus 108 (5.5%)
 Upper lobe, lung 621 (31.7%)
 Middle lobe, lung 337 (17.2%)
 Lower lobe, lung 792 (40.5%)
 Overlapping lesion of lung 37 (1.9%)
 Lung, NOS 61 (3.2%)
Grade
 Well 1451 (74.2%)
 Moderately/Poorly/Undifferentiated 505 (25.8%)
Laterality
 Right 1142 (58.4%)
 Other 814 (46.4%)
Historic Stage
 Localized 1389 (71.0%)
 Regional/Distant/Unstaged 567 (29.0%)
Histological type
 Typical carcinoid 1702 (87.0%)
 Atypical carcinoid 254 (13.0%)
T stage
 T1 1133 (57.9%)
 T2-T4 823 (42.1%)
N stage
 N0 1622 (83.0%)
 N1-N3 334 (17.0%)
M stage
 M0 1814 (92.7%)
 M1 142 (7.3%)
Surgery
 No 225 (11.5%)
 Lobectomy 1235 (63.1%)
 Local 119 (6.1%)
 Wedge 264 (13.5%)
 Pneumonectomy 103 (5.3%)
 NOS 10 (0.5%)
Radiation
 No 1847 (94.4%)
 Yes 109 (5.6%)
Chemotherapy
 No 1843 (94.2%)
 Yes 113 (5.8%)
Radiation after surgery
 No 1898 (97.0%)
 Yes 58 (3.0%)
Tumor size
  < 20 mm 841 (43.0%)
 20–40 mm 873 (44.6%)
  > 40 mm 242 (12.4%)